Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Facebook X (Twitter) Instagram
Friday, June 5
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Advantage
  • Home
  • International

    Medical Cannabis Patients Report Reduced Prescription Drug Use

    May 8, 2026

    Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

    May 6, 2026

    Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

    March 7, 2026
  • News

    Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

    June 5, 2026

    Exercise common amongst cannabis users, new study finds

    June 5, 2026

    Amsterdam Drops Coffeeshop Tourist Ban In New Coalition Deal

    June 4, 2026

    Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move

    June 4, 2026

    UK Medical Cannabis Patients Report Improved Mental Health Symptoms

    June 3, 2026
  • Lifestyle

    Rappin’ The Rivers Is Building Montana’s Hip-Hop Outpost

    June 4, 2026

    Harry Styles Says He Did A Lot of Mushrooms Making ‘Fine Line.’ A Top Psychedelic Scientist Explains Why It Tracks.

    May 31, 2026

    Twenty-One Years Later, Conor Oberst Is More Wide Awake Than Ever

    May 29, 2026

    What the VA Won’t Prescribe: A Joint

    May 27, 2026

    Scary Movie Went All In On Marketing To Stoners. A Vape, A Bong Popcorn Bucket, The Whole Thing.

    May 25, 2026
  • Law

    Client Challenge

    June 5, 2026

    Kentucky Gov. Signs Order to Add 15 New Qualifying Conditions for Medical Cannabis

    June 4, 2026

    Minnesota Gov. Signs Law Streamlining Medical and Adult-Use Cannabis Supply Chains

    June 2, 2026

    NORML Seeks to Participate in DEA Hearings on Cannabis Rescheduling 

    May 29, 2026

    Massachusetts Regulators to Audit Cannabis THC Potency Levels

    May 26, 2026
  • Business

    They Already Ruined Cannabis. Now Psychedelics Are Next.

    June 5, 2026

    The Cannabis Consumer Has Grown Up. Has Your Hardware?  – Cannabis & Tech Today

    June 4, 2026

    Pre-Rolls Overtake Flower as Consumer Preferences Shift – Cannabis & Tech Today

    May 30, 2026

    Marc Shepard Built NECANN for the Locals

    May 29, 2026

    Federal Labor Decision Inspires More Missouri Marijuana Workers To Seek Unionization

    May 27, 2026
  • Education

    The “Canna-Tourism” Guide to the Twin Cities

    June 4, 2026

    CBD Dosage Guide for Beginners (India) – Buy CBD Oil India | Licensed Under Ministry of Ayush

    June 2, 2026

    Marijuana Components Have ‘Consistent’ Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows

    May 31, 2026

    Beyond Cannabinoids: Unlocking Cannabistilbenes

    May 29, 2026

    How the Endocannabinoid System Controls Sleep, Mood & Pain – Buy CBD Oil India | Licensed Under Ministry of Ayush

    May 27, 2026
  • Vaping

    France’s Criminilization of Nicotine Pouches Raises Questions Over Tobacco Harm Reduction Policy

    June 4, 2026

    Psychedelics, Vapes and Smart Apps: Smoking Cessation Science Evolves Beyond Traditional NRTs

    June 2, 2026

    Review: Coolfire Z Air – Innokin

    May 31, 2026

    Tobacco Harm Reduction: An Especially Beneficial Public Health Tool for Disadvantaged Groups

    May 29, 2026

    Global Vaping Research 2026: Cancer Concerns, Nicotine Science and Smoking Cessation Evidence

    May 27, 2026
Smoke Advantage
You are at:Home»Education»High Marijuana Taxes Don’t Effectively Deter Use, Study Shows, Contrary To NYT Editorial Board’s Claim
Education

High Marijuana Taxes Don’t Effectively Deter Use, Study Shows, Contrary To NYT Editorial Board’s Claim

adminBy adminMarch 29, 2026No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

There’s no meaningful evidence that imposing higher taxes on marijuana would steer people away from using it—contrary to a claim recently made by the The New York Times editorial board—according to a new scientific analysis of cannabis consumption and tax data.

In fact, raising the cost of cannabis sold at state-licensed retailers could lead people to return to the illicit market to obtain cheaper (and untested) marijuana that carries its own public health and safety risks.

The new report, authored by Ohio State University (OSU) Moritz College of Law researchers Dexter Ridgway and Jana Hrdinová, drew on nationally representative survey data from federal sources and marijuana tax rates in states that have enacted legalization to test the idea that putting a higher premium on cannabis for adults could positively influence consumer behavior and deter heavy marijuana use.

In its editorial, the board emphasized that while the federal government imposes taxes on alcohol and tobacco sales, it doesn’t do the same for marijuana—which is no surprise given that the plant remains federally illegal, as do the state-licensed shops that sell it. The board said “increases in tobacco taxes have been a major reason that its use has declined during the 21st century, with profound health benefits.”

“The first step in a strategy to reduce marijuana abuse should be a federal tax on pot. States should also raise taxes on pot; today, state taxes can be as low as a few additional cents on a joint,” the editorial argued. “Taxes should be high enough to deter excessive use, on the scale of dollars per joint, not cents.”

The idea that high marijuana taxes are causally associated with lower usage rates isn’t exactly settled science, the OSU report said, as states with varying tax rates for cannabis have seen disparate trends in consumer behavior.

“More generally, at a time when the legal cannabis marketplace is a patchwork of ever-changing state laws and industries, the overall relationship between tax rates and marijuana use rates (and especially heavy use rates) is quite unclear,” the researchers wrote.

They pointed out, for example, that marijuana is taxed at the highest rate in Washington State (43.5 percent), and the state has the sixth highest usage rate (22 percent) in the dataset. By contrast, New Jersey has the lowest tax rate (6.6 percent) and reports the lowest usage rate (14.4 percent), ranking in the bottom half nationally.

“These patterns do not imply that taxes have no effect on consumption, but they do suggest that assuming marijuana users will respond to taxation like tobacco users is overly simplistic,” the report says.

Via OSU.

Ultimately, the OSU report—which assessed 2023-2024 survey data from the federal Substance Abuse and Mental Health Services Administration (SAMHSA)—concluded that “there is no apparent correlation between marijuana tax rate and marijuana usage rate.”

“Merely looking at tax rates and usage rates ignores the myriad of other factors that can influence the rate of use, such as the maturity of the legal market, the ease of access to product affected by number of dispensaries per population, the price of the product in a given state (since marijuana cannot be traded across state lines, the way states regulate the number of licensed growers significantly affects availability/price of product) and many other factors,” the researchers said.

“The New York Times editorial soundly stressed the importance, from a public health perspective, of limiting excessive or high potency marijuana use. Additional data is needed to assess the role of tax increases to deter the riskiest marijuana uses and users, and policy progress here will likely require a broader regulatory approach, besides taxation. These 2023 data suggest no simple inverse relationship between state tax rates and marijuana use, and effective policy must account for market structure, product availability and the wide availability of illicit product.”

Via OSU.

To be sure, where the editorial board, advocates and researchers seem to align is in their shared position that the federal government’s decades-long prohibitionist policies and the resulting lack of robust regulations is a problem. States have been passively permitted to participate in the cannabis experiment without federal safeguards in place or guidance on policy issues such as cannabis tax rates or potency limits for marijuana products, for example.

The marijuana tax policy discussion has continued to play out in states and cities across the U.S. where marijuana laws are being considered or tweaked. There might not be consensus around the appropriate tax rate for cannabis, but there’s a general understanding that governments must balance revenue interests with the need to make regulated cannabis products cost-competitive with the illicit market.

The Times editorial board further argued in its piece that an “advantage of taxes is that they fall much more on heavy users than casual smokers.”

“If a joint cost $10 instead of $5, it would mean a lot of extra money for someone now smoking multiple joints a day and may change that person’s behavior,” it said in the editorial, which has faced scrutiny from multiple skeptical sources. “It would not be a big burden for someone who smokes occasionally.”

But as the OSU analysis argues, there’s “reason to fear that significantly higher tax rates for marijuana products could shift use into unregulated and more dangerous illicit markets rather than to deter or reduce problematic cannabis use.”

At the federal level, marijuana may soon be moved from Schedule I to Schedule III of the Controlled Substances Act (CSA), which wouldn’t federally legalize the plant but would free up certain research barriers and allow state-licensed cannabis businesses to take federal tax deductions they’ve been barred from under Internal Revenue Service (IRS) code 280E.

That latter effect is expected to give the cannabis sector an economic boost, but because marijuana products would remain illegal to sell under federal law, rescheduling alone wouldn’t necessarily create a clear pathway for a new federal tax as the Times editorial board is proposing.

Removing the 280E penalty could also potentially bring cannabis prices down if industry operators decide to pass any of their tax savings on to the consumer.

“The federal government needs to be part of these solutions. Leaving taxes and regulations to the states threatens to create a race to the bottom in which people can cross state lines to buy their pot,” the board said. “Congress can set a floor, as it has done, however inadequately, with alcohol and tobacco, and states can build on it as they choose.”

Various congressional bills to legalize cannabis have included federal tax provisions, with specific appropriations in mind for the revenue, but none of those have advanced in the current Congress.

Source link

Boards Claim Contrary Deter Dont Editorial Effectively High Marijuana NYT Shows study Taxes
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleDouble Victory: VAPORESSO and DOJO Recognized at Vapexpo Paris 2026
Next Article How to Execute a Successful Thought Leadership Campaign – Cannabis & Tech Today
admin

Related Posts

Exercise common amongst cannabis users, new study finds

June 5, 2026

The “Canna-Tourism” Guide to the Twin Cities

June 4, 2026

Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move

June 4, 2026

Comments are closed.

Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Law

Client Challenge

By adminJune 5, 20260

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required…

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Sponsors
Copyright © 2026. SmokeAdvantage.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.